M/S BOSTON SCIENTIFIC INDIA PVT. LTD.,,NEW DELHI vs. ACIT, NEW DELHI
In the result, the appeal of the assessee is partly allowed for statistical purposes
ITA 6806/DEL/2015[2011-12]Status: DisposedITAT Delhi30 Nov 2016AY 2011-12
Bench: Sh. N. K. Saini, Am & Ms. Suchitra Kamble, Jm Ita No. 6806/Del/2015 : Asstt. Year : 2011-12 Boston Scientific India Pvt. Ltd., Vs Asstt. Commissioner Of Income C-40/41, Okhla Industrial Area, Tax, Circle-5(1), Phase-2, New Delhi-110020 New Delhi-110002 (Appellant) (Respondent) Pan No. Aabcg9446Q Assessee By : Sh. M. S. Syali, Sr. Adv., Sh. Tarandeep Singh, Adv. & Sh. Tarun Singh, Adv. Revenue By : Sh. Sanjay I. Bara, Cit Dr Date Of Hearing : 05.07.2018 Date Of Pronouncement : 31.08.2018 Order Per N. K. Saini, Am: This Is An Appeal By The Assessee Against The Order Dated 30.11.2015 Passed By The Ao U/S 143(3) R.W.S. 144C Of The Income Tax Act, 1961 (Hereinafter Referred To As The Act).
For Appellant: Sh. M. S. Syali, Sr. AdvFor Respondent: Sh. Sanjay I. Bara, CIT DR
Section 143(3)Section 260ASection 37(1)
…esaid referred to order of the Co- ordinate bench, we are of the view that the disallowance made by the AO was not justified. 8. A similar view has been taken by the ITAT Mumbai Bench in the case of Solvay Pharma India Ltd. Vs Pr. CIT, Range-2, Mumbai (2018) 169 ITD 13 wherein it has been held as under: “The CBDT Circular dated 1-8-2012 (supra) in its clarification has enlarged the scope and applicability of 'Indian Medical Council Regulations, 2002' by making it applicable to the pharmaceutical companies or allied 8 Boston Scientific India Pvt. Ltd. healthcare sector industries. Such an enlargement of scope of…